Banque Cantonale Vaudoise Bausch Health Companies Inc. Transaction History

Banque Cantonale Vaudoise

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 20, 2023	SELL	$6.28 - $9.85 $12,560 - $19,700	-2,000 Reduced 57.14%	1,500 $12,000
Q2 2022 Aug 02, 2022	BUY	$7.06 - $23.63 $10,590 - $35,445	1,500 Added 75.0%	3,500 $30,000
Q1 2022 May 09, 2022	BUY	$21.6 - $27.79 $43,200 - $55,580	2,000 New	2,000 $46,000
Q4 2020 Feb 05, 2021	SELL	$15.31 - $21.12 $36,590 - $50,476	-2,390 Closed	0 $0
Q3 2020 Oct 30, 2020	BUY	$14.88 - $20.13 $35,563 - $48,110	2,390 New	2,390 $37,000

258

255M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.33B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Banque Cantonale Vaudoise, based on Form 13F filings with the SEC.

Stay updated on Banque Cantonale Vaudoise with notifications on news.